companydata.dkcompanydata.dk

ABL BIOTEC A/S: Financial statements 2015

CVR: 50811018

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -122,431 and a net result of DKK 2,230,370 compared with DKK 3,774,071 the year before. Equity in the 2015 report amounted to DKK 24,842,691. The solvency ratio was 99.5%.

Gross Profit
DKK -122,431
Profit/Loss
DKK 2,230,370
Equity
DKK 24,842,691
Total Assets
DKK 24,969,295

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015--122K2.2M24.8M-
2014--100K3.8M23.7M-
2013--97K2.7M22.4M-
2012--51K3.7M21.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ABL BIOTEC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

ABL BIOTEC A/S: The 2014 annual report is outMar 26, 2015

ABL BIOTEC A/S has published its annual report for 2014. Gross profit came to DKK -100,370, and the net result was DKK 3,774,071.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.

Source: annual report 2025, Danish Business Authority